Grandfield & Dodd’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-7,820
Closed -$800K 172
2014
Q4
$800K Sell
7,820
-19
-0.2% -$1.82K 0.12% 89
2014
Q3
$678K Sell
7,839
-7,005
-47% -$620K 0.11% 96
2014
Q2
$1.34M Sell
14,844
-150
-1% -$11.2K 0.2% 86
2014
Q1
$1.1M Sell
14,994
-5,525
-27% -$385K 0.17% 90
2013
Q4
$1.4M Sell
20,519
-2,407
-10% -$157K 0.23% 82
2013
Q3
$1.4M Sell
22,926
-8,984
-28% -$548K 0.25% 81
2013
Q2
$1.78M Buy
+31,910
New +$1.85M 0.34% 71

Grandfield & Dodd's COV Position: Q1 2015 in Review

Grandfield & Dodd sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 7,820 shares — an estimated $800K sold.

Grandfield & Dodd first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $1.78M in Q2 2013. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Grandfield & Dodd reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Grandfield & Dodd sold 7,820 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $800K.
  • Grandfield & Dodd first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Grandfield & Dodd's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.78M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Grandfield & Dodd's 13F filing for Q1 2015, filed 15 May 2015.